Approvals for Shire’s attention deficit / hyperactivity disorder (ADHD) treatment Elvanse® is imminent in eight European states. Elvanse is specifically indicated as part of a comprehensive treatment ...
Children in Scotland with attention-deficit hyperactivity disorder (ADHD) have gained access to a new treatment option after regulators agreed to fund Shire's Elvanse on the National Health Service.
Shire is celebrating the news that approvals in eight European states are imminent for its attention deficit/hyperactivity disorder blockbuster Vyvanse, which will be marketed as Elvanse. Shire is ...
Shire launches Elvanse Adult ®Description: BT_1000x858px (lisdexamfetamine dimesylate), the first licensed stimulant treatment for adults with ADHD in the UK Basingstoke, UK – 26 August 2015 – Shire ...
Nyon, Switzerland – February 19, 2014 – Shire plc (LSE: SHP, NASDAQ: SHPG) today announced the acceptance for review of an application for an adult indication, for their once-daily Attention ...
Hosted on MSN
City analyst, 28, died days after ADHD medication was increased as coroner calls for drug review
A coroner has urged a review following the death of a young City finance worker of heart issues just days after his ADHD medication dosage was increased. Coroner Sarah Bourke has called on the ...
A coroner has urged a review following the death of a young City finance worker of heart issues just days after his ADHD medication dosage was increased. Coroner Sarah Bourke has called on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results